Although a weakness of our study is that the relatively small size of the patient cohort inhibited our ability to make strong conclusions, noteworthy relationship was observed between polymorphisms of the CDKN1B and CCND2 genes and CLL course. This evidence concerns the gene CCND2 and B-cell chronic lymphocytic leukemia.